News Sanofi Pasteur and MSD end vaccines joint venture Companies end collaboration after more than 20 years.
News Lilly and Boehringer biosimilar undercuts Lantus by 15% Sanofi under pressure following long-awaited biosimilar launch.
US Vericel hopes for US hit with Maci knee treatment Tissue engineering product previously flopped in EU.
News Sanofi outbids J&J for Actelion merger - reports Reports suggest Sanofi could pay $30 billion for Swiss biotech.
News Good news for Amgen as Repatha reverses atherosclerosis Encouraging data could point to strong outcomes data, expected next year
Views & Analysis GSK and Sanofi CEOs: it's drug prices, stupid How pharma can move on from the recent controversies around pricing is one of the industry's biggest issues.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.